Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

NCT03514511 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: LEO 138559
DRUG: LEO 138559 placebo

Sponsor

LEO Pharma